Pancreatic Cancer Research

ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years

Tianshu Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2318-2869; OpenAlex author ID A5100677110. Sources: ClinicalTrials.gov.

Their work

Papers
3
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
33
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: 1 trial · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper

Papers 3

  1. Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial. Co-author DOI 10.3892/ol.2024.14293↗
  2. Nimotuzumab Plus Gemcitabine for K-Ras Wild-Type Locally Advanced or Metastatic Pancreatic Cancer. Co-author DOI 10.1200/jco.22.02630↗
  3. Efficacy and safety comparison of nabpaclitaxel plus S-1 and gemcitabine plus S-1 as first-line chemotherapy for metastatic pancreatic cancer. Co-author DOI 10.1093/jjco/hyy063↗

Trials 1

  1. PT-112 (Phosplatin's Platinum) Combine With Gemcitabine Injection for Advanced Solid Tumors Principal investigator NCT05357196↗

Closest collaborators

The 25 strongest of 33 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Deliang Fu · 2 shared papers, 2023–2024 · strength 0.29
  2. Yaolin Xu · 2 shared papers, 2018–2024 · strength 0.23
  3. Xi Guo · 2 shared papers, 2018–2024 · strength 0.23
  4. Lili Wu · 2 shared papers, 2018–2024 · strength 0.23
  5. Dansong Wang · 2 shared papers, 2018–2024 · strength 0.23
  6. Wenchuan Wu · 2 shared papers, 2018–2024 · strength 0.23
  7. Lie Yao · 1 shared paper, 2024 · strength 0.16
  8. Xuefeng Xu · 1 shared paper, 2024 · strength 0.16
  9. Yuan Ji Ma · 1 shared paper, 2024 · strength 0.16
  10. Yefei Rong · 1 shared paper, 2024 · strength 0.16
  11. Wenquan Wang · 1 shared paper, 2024 · strength 0.16
  12. Liang Liu · 1 shared paper, 2024 · strength 0.16
  13. Wenhui Lou · 1 shared paper, 2024 · strength 0.16
  14. Dayong Jin · 1 shared paper, 2024 · strength 0.16
  15. Yuhong Zhou · 1 shared paper, 2024 · strength 0.16
  16. Tiantao Kuang · 1 shared paper, 2024 · strength 0.16
  17. Jing Liu · 1 shared paper, 2024 · strength 0.16
  18. Jun Zhang · 1 shared paper, 2024 · strength 0.16
  19. Xiaowei Liu · 1 shared paper, 2024 · strength 0.16
  20. Chunyi Hao · 1 shared paper, 2023 · strength 0.13
  21. Ying Yuan · 1 shared paper, 2023 · strength 0.13
  22. Hongmei Zhang · 1 shared paper, 2023 · strength 0.13
  23. Lin Yang · 1 shared paper, 2023 · strength 0.13
  24. Lin Shen · 1 shared paper, 2023 · strength 0.13
  25. Jianming Xu · 1 shared paper, 2023 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.